Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership

Learn More

Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
12 NEW May 16, 2022
Dr. Michael Linenberger honored for contributions to apheresis medicine

Dr. Michael Linenberger honored for contributions to apheresis medicine

Presidential Award from American Society for Apheresis recognizes hematologist’s two decades of service
Hutch News - March 07, 2022
Black with cancer: ‘It shouldn’t be different’

Black with cancer: ‘It shouldn’t be different’

Hutch/UW Consortium health equity team works to reduce cancer risk and racial bias, improve care for Black communities and patients
Hutch News - June 14, 2021
Challenges and Recommendations for COVID-19 Vaccines in patients with cancer

Challenges and Recommendations for COVID-19 Vaccines in patients with cancer

The Lyman Group, Division of Public Health Sciences
Science Spotlight - April 19, 2021
One more hat: new roles for TGFβ in the DNA damage response

One more hat: new roles for TGFβ in the DNA damage response

From the Paulovich Lab, Clinical Research Division, and colleagues
Science Spotlight - March 15, 2021
Outlining the molecular networks that alter cell function and behavior

Outlining the molecular networks that alter cell function and behavior

Dr. Taran Gujral’s NSF CAREER Award will allow him to study how cells shift to new functional states in normal development and disease
Hutch News - March 04, 2021
Patients navigate cancer during COVID-19 pandemic

Patients navigate cancer during COVID-19 pandemic

Scary waiting rooms, delayed scans and ‘virtual’ care: patients and providers try to dodge the collateral damage of coronavirus
Hutch News - October 13, 2020
YAP1 gene fusions are oncogenic drivers in several tumor types and potential therapeutic targets

YAP1 gene fusions are oncogenic drivers in several tumor types and potential therapeutic targets

From the Holland, Paddison, Vasioukhin, and Gujral labs, Human Biology Division
Science Spotlight - September 21, 2020
'Everything we’ve been training for is happening now'

'Everything we’ve been training for is happening now'

How early-career virologists dropped everything to seize the opportunity, and face the challenges, of studying the coronavirus
Hutch News - September 16, 2020
Stalled science, missed mates and virtual everything

Stalled science, missed mates and virtual everything

Torn between science and safety concerns, young scientists navigate a new normal as they try to launch their careers
Hutch News - September 15, 2020
Public health’s pandemic pivot

Public health’s pandemic pivot

With disease modeling, virtual events and a renewed focus on antiracism, Fred Hutch population scientists adapt their work to COVID-19
Hutch News - September 15, 2020
Activation of developmental pathways correlates with poor clinical outcomes across cancer types

Activation of developmental pathways correlates with poor clinical outcomes across cancer types

From the Gujral lab, Human Biology Division
Science Spotlight - August 17, 2020
The NTRK2 splice variant TrkB.T1 plays a vital role in human glioma

The NTRK2 splice variant TrkB.T1 plays a vital role in human glioma

From the Holland lab, Human Biology Division
Science Spotlight - August 17, 2020
Obliteride brings in $2M to spur cancer, COVID-19 research

Obliteride brings in $2M to spur cancer, COVID-19 research

Annual Fred Hutch fundraiser goes virtual and DIY; sets records for participation, creativity and global reach
Hutch News - August 11, 2020
Last Modified, April 02, 2020